Cargando…
S100A gene family: immune-related prognostic biomarkers and therapeutic targets for low-grade glioma
Background: Despite the better prognosis given by surgical resection and chemotherapy in low-grade glioma (LGG), progressive transformation is still a huge concern. In this case, the S100A gene family, being capable of regulating inflammatory responses, can promote tumor development. Methods: The an...
Autores principales: | Zhang, Yu, Yang, Xin, Zhu, Xiao-Lin, Bai, Hao, Wang, Zhuang-Zhuang, Zhang, Jun-Jie, Hao, Chun-Yan, Duan, Hu-Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221329/ https://www.ncbi.nlm.nih.gov/pubmed/34148033 http://dx.doi.org/10.18632/aging.203103 |
Ejemplares similares
-
A Novel Immune-Related Prognostic Biomarker and Target Associated With Malignant Progression of Glioma
por: Zhang, Yu, et al.
Publicado: (2021) -
OSlgg: An Online Prognostic Biomarker Analysis Tool for Low-Grade Glioma
por: An, Yang, et al.
Publicado: (2020) -
PTPRN Serves as a Prognostic Biomarker and Correlated with Immune Infiltrates in Low Grade Glioma
por: Li, Peng, et al.
Publicado: (2022) -
METTL21B is a prognostic biomarker and potential therapeutic target in low-grade gliomas
por: Shu, Xin, et al.
Publicado: (2021) -
Immunological and prognostic analysis of PSENEN in low-grade gliomas: An immune infiltration-related prognostic biomarker
por: Chen, Kaijie, et al.
Publicado: (2022)